Literature DB >> 9321402

Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.

M McCoy1, E S Stavridi, J L Waterman, A M Wieczorek, S J Opella, T D Halazonetis.   

Abstract

The p53 tumor suppressor oligomerization domain, a dimer of two primary dimers, is an independently folding domain whose subunits consist of a beta-strand, a tight turn and an alpha-helix. To evaluate the effect of hydrophobic side-chains on three-dimensional structure, we substituted residues Phe341 and Leu344 in the alpha-helix with other hydrophobic amino acids. Substitutions that resulted in residue 341 having a smaller side-chain than residue 344 switched the stoichiometry of the domain from tetrameric to dimeric. The three-dimensional structure of one such dimer was determined by multidimensional NMR spectroscopy. When compared with the primary dimer of the wild-type p53 oligomerization domain, the mutant dimer showed a switch in alpha-helical packing from anti-parallel to parallel and rotation of the alpha-helices relative to the beta-strands. Hydrophobic side-chain size is therefore an important determinant of a protein fold.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321402      PMCID: PMC1326307          DOI: 10.1093/emboj/16.20.6230

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Contribution to the thermodynamics of protein folding from the reduction in water-accessible nonpolar surface area.

Authors:  J R Livingstone; R S Spolar; M T Record
Journal:  Biochemistry       Date:  1991-04-30       Impact factor: 3.162

2.  Alternative packing arrangements in the hydrophobic core of lambda repressor.

Authors:  W A Lim; R T Sauer
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Structural and energetic consequences of disruptive mutations in a protein core.

Authors:  W A Lim; D C Farruggio; R T Sauer
Journal:  Biochemistry       Date:  1992-05-05       Impact factor: 3.162

4.  Genetic and structural analysis of the protein stability problem.

Authors:  B W Matthews
Journal:  Biochemistry       Date:  1987-11-03       Impact factor: 3.162

5.  Solution structure of the tetrameric minimum transforming domain of p53.

Authors:  W Lee; T S Harvey; Y Yin; P Yau; D Litchfield; C H Arrowsmith
Journal:  Nat Struct Biol       Date:  1994-12

Review 6.  3D domain swapping: a mechanism for oligomer assembly.

Authors:  M J Bennett; M P Schlunegger; D Eisenberg
Journal:  Protein Sci       Date:  1995-12       Impact factor: 6.725

7.  p53 domains: structure, oligomerization, and transformation.

Authors:  P Wang; M Reed; Y Wang; G Mayr; J E Stenger; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Refined solution structure of the oligomerization domain of the tumour suppressor p53.

Authors:  G M Clore; J Ernst; R Clubb; J G Omichinski; W M Kennedy; K Sakaguchi; E Appella; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1995-04

9.  A pulsed field gradient isotope-filtered 3D 13C HMQC-NOESY experiment for extracting intermolecular NOE contacts in molecular complexes.

Authors:  W Lee; M J Revington; C Arrowsmith; L E Kay
Journal:  FEBS Lett       Date:  1994-08-15       Impact factor: 4.124

10.  The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.

Authors:  J L Waterman; J L Shenk; T D Halazonetis
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  11 in total

Review 1.  Utilizing NMR to study the structure of growth-inhibitory proteins.

Authors:  Francesca Marassi
Journal:  Methods Mol Biol       Date:  2003

2.  Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.

Authors:  M G Mateu; A R Fersht
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.

Authors:  E S Stavridi; N H Chehab; L C Caruso; T D Halazonetis
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

4.  A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

5.  One-Dimensional Search Dynamics of Tumor Suppressor p53 Regulated by a Disordered C-Terminal Domain.

Authors:  Agato Murata; Yuji Itoh; Eriko Mano; Saori Kanbayashi; Chihiro Igarashi; Hiroto Takahashi; Satoshi Takahashi; Kiyoto Kamagata
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

6.  NAD+ modulates p53 DNA binding specificity and function.

Authors:  Kevin G McLure; Masatoshi Takagi; Michael B Kastan
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  Disruption of an intermonomer salt bridge in the p53 tetramerization domain results in an increased propensity to form amyloid fibrils.

Authors:  Charles Galea; Prentice Bowman; Richard W Kriwacki
Journal:  Protein Sci       Date:  2005-10-31       Impact factor: 6.725

8.  Soft-shell clam (Mya arenaria) p53: a structural and functional comparison to human p53.

Authors:  Lauren A C Holbrook; Rondi A Butler; Robert E Cashon; Rebecca J Van Beneden
Journal:  Gene       Date:  2008-12-11       Impact factor: 3.688

9.  Structural evolution of C-terminal domains in the p53 family.

Authors:  Horng Der Ou; Frank Löhr; Vitali Vogel; Werner Mäntele; Volker Dötsch
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

10.  DisPredict: A Predictor of Disordered Protein Using Optimized RBF Kernel.

Authors:  Sumaiya Iqbal; Md Tamjidul Hoque
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.